The FAMCare Blog

Fostering discussions on industry news, effective data management, improved workflow, morale and funding.

Global Vision Technologies, Creators of FAMCare Case Management Software Celebrates 20 Year Anniversary

From 24-7 Press Release.com

ST. LOUIS, MO, September 12, 2017 /24-7PressRelease/ -- Global Vision Technologies' (GVT) is proud to announce its twentieth year as a leading developer of case management software for human services. GVT has achieved two decades of innovation and steady growth helping social service and healthcare agencies leverage technology to improve record keeping, workflow and outcomes.

Read More
September 12 ,2017

First Worldwide Patient-Empowered Research Tool Launched by AARDA

Registry Empowers Patients to Participate in Clinical Research, Advanced Medical Knowledge About Autoimmunity

Newswise — DETROIT, February 7, 2017 – Ushering in March as National Autoimmune Disease Awareness Month, the American Autoimmune Related Diseases Association, Inc. (AARDA) today unveiled the Autoimmune Research Network, known as ARNet, the world’s first fully-functioning patient registry for individuals diagnosed with one or more of the 100-plus known autoimmune diseases (ADs).

The result of two years of beta-testing by AARDA, ARNet facilitates research into autoimmunity and autoimmune diseases by creating one comprehensive, central database of anonymous patient information. Such information includes diagnosed diseases and other demographics that investigators around the world can use to enlist patients in clinical research studies. In addition, ARNet will help researchers answer epidemiological questions, identify trends, and track the number of patients with certain ADs and their experience obtaining a correct diagnosis.

Managed by Global Vision Technologies, a pioneering firm specializing in custom-tailored, HIPAA compliant patient registries, the ARNet database currently contains information for nearly 10,000 patients and continues to grow.

“With this ‘big data’ project, AARDA’s hope is to drive much-needed clinical research into the numerous and wide-ranging ADs, including the rheumatic, neurologic, dermatologic, endocrine and so on. This research ultimately will help improve time to diagnosis of these diseases, as well as advance knowledge into causes, treatments and perhaps cures,” said Virginia T. Ladd, Founder and Executive Director, AARDA.

Despite the fact that ADs affect more Americans (more than 50 million) than do cancer (approximately 15 million) and heart disease (approximately 28 million), federal research for autoimmune diseases is significantly underfunded. According to the National Institutes of Health, in 2016 federal research funding for ADs was $821 million compared to $5.4 billion for cancer and $1.7 billion for heart disease.

Working in collaboration with National Coalition of Autoimmune Patient Groups (NCAPG) member organizations and other interested parties, AARDA is encouraging AD patients to sign on to the registry, get involved and be part of the solution as researchers, both academic and commercial across the globe work to understand the puzzle that is autoimmunity.

“By opening ARNet to researchers and patients, we seek to fill in some of those research gaps and foster projects that uncover knowledge that will benefit all autoimmune diseases – not just one or two,” said Ladd.

Currently, participating NCAPG organizations include Relapsing Polychondritis Awareness and Support Foundation, the National Adrenal Diseases Foundation, Conquer Myasthenia Gravis and AARDA.

“As a member of the ARNet Steering Committee, the Relapsing Polychondritis Awareness and Support Foundation is pleased to be involved in the development of ARNet, a tool that both researchers and members can use to leverage the power of patient data while at the same time giving the patients a degree of control over their disease that very often leaves the people involved in their care and the patient themselves feeling out of control,” said Tom Christie, CEO, Relapsing Polychondritis Awareness and Support Foundation.

How it Works for Patients -- Confidentially
Patients who have been diagnosed with one or more autoimmune disease can register online at AARDA’s website (www.aarda.org) or the websites of participating NCAPG groups.

The information is anonymous and made available to researchers interested in looking at the “bigger autoimmune picture.” The database allows them to do queries on multiple data sources at once. When investigators identify an individual appropriate for a clinical trial, they contact AARDA or the originating NCAPG group who in turn contacts the patient (who up until this point has remained anonymous). Once the patient agrees, AARDA or the NCAPG group issues an invitation to the patient regarding his/her potential participation in the study, eventually connecting him/her with the researcher.

About Global Vision Technologies
Global Vision Technologies (GVT) is a technology consulting and software development firm that specializes in delivering custom-tailored, HIPAA compliant patient registry solutions for organizations who are looking for a specific application to solve their patient data collection, compliance and reporting/analysis needs. GVT’s solution – ClinicalPURSUIT, is a web-based application that allows data entry to be collected securely over the web making the data immediately “actionable” and ready for analysis. For more information, visit www.globalvisiontech.com and www.patientregistrysoftware.com

About Autoimmune Diseases
There are more than 100 known autoimmune diseases, including psoriasis, Addison’s disease, Graves’ disease, Sjogren’s syndrome, Type 1 diabetes, relapsing polychondritis, myasthenia gravis, multiple sclerosis, rheumatoid arthritis, Crohn’s disease and lupus. The underlying cause of all of these diseases is autoimmunity which disproportionately affects women. Of the 50 million Americans living and coping with ADs, more than 75 percent are women. Given the genetic component, autoimmune diseases can run in families. AD is one of the top 10 leading causes of death of women under the age of 65 and is responsible for more than $100 billion in direct health care costs annually.

About American Autoimmune Related Diseases Association
Celebrating its 25th anniversary, American Autoimmune Related Diseases Association (AARDA) is the nation's only non-profit organization dedicated to bringing a national focus to autoimmunity as a category of disease and a major women's health issue, and promoting a collaborative research effort in order to find better treatments and a cure for all autoimmune diseases. For more information, please visit www.aarda.org .

Follow us on social media, including:
Facebook ( www.facebook.com/Autoimmunity  )
Twitter (@AARDATweets)
YouTube ( www.youtube.com/AARDATube  )

CONTACT:
Cindy Carway/Stephanie Hornback
Carway Communications, Inc.
212-378-2020
[email protected] 
@CarwayComms

Read More
February 08 ,2017

Anti-Recidivism Coalition Chooses FAMCare to Improve Outcomes of Formerly Incarcerated Individuals

PRESS RELEASE

St. Louis, MO – A.R.C. (Anti-Recidivism Coalition), a support network and advocacy group for men and women who were once incarcerated and part of the criminal justice system, has partnered with Global Vision Technologies, Inc. (GVT) to implement FAMCare human services software.

Read More
June 30 ,2016

CASPA Chooses FAMCare Case Management Software to Help At-Risk Kids and Families

PRESS RELEASE: March 21, 2016

St. Louis, MO – CASPA (Child and Adolescent Specialist Programs and Accommodation), an Australian agency that supports and rebuilds the lives of children in foster care, and at-risk children and their families, has partnered with Global Vision Technologies, Inc. (GVT) to implement FAMCare human services software for their foster care and case management needs. The goal of FAMCare will be to help with structured information collection and analysis as they work with children and adolescents with complex needs and problems.

Read More
March 22 ,2016

Global Vision Technologies Inc., Launches FAMCare 5, Simple, Powerful Case Management Software for Any Population

Global Vision Technologies, Inc., (GVT) the creator of FAMCare, has just launched the next evolution of case management software, FAMCare 5, a 5 user case management platformintended to help agencies with budget constraints or who would just like to ‘kick the tires’ - take advantage of powerful technology, at an affordable cost.  

Read More
November 06 ,2015

Global Vision Technologies Exhibiting at Michigan Federation Senior Management Conference

Read More
September 16 ,2015

Long Term Care Services Providers About to be Swamped

Read More
August 14 ,2015

Global Vision Technologies Reports Great Turnout At Case Management Software Conference

Read More
August 07 ,2015

Case Management Software To Be Launched At The Foster Families Treatment Association National Conference

Read More
July 31 ,2015

Global Vision Technologies Achieves Multi-National Data Privacy Certification (Safe Harbor)

Hello - I wanted to share a recent press release with you.

Read More
January 28 ,2015

Subscribe to Email Updates

 
CrowdReviews.com Logo
The crowd rates us 4.5 out of 5.0

Read all 8 Reviews / Write A Review

 

The Top 10 FAMCare FAQ Video Series

The Top 10 FAMCare FAQ Video SeriesHow does it work?  How will it save me time? 

 

How can I change it and make it my own? Is it HIPAA compliant? 

How will it help me attract more funding?  How will it keep my caseworkers focused?

    

QUESTIONS everyone wants to know.  We've developed a video series that reveals in 3-5 minute "VIDBITS"... live-action and video simulation answers to some of the most frequently asked questions about FAMCare CONNECT.
    

Access

 

 

Latest Articles